Mechanisms of Cardiotoxicity Associated with Tyrosine Kinase Inhibitors in H9c2 Cells and Mice

Código QR

Mechanisms of Cardiotoxicity Associated with Tyrosine Kinase Inhibitors in H9c2 Cells and Mice

Guardado en:

Detalles Bibliográficos
Autores principales:	J Bouitbir, A Alshaikhali, M Panajatovic, V Abegg, F Paech, S Krähenbühl
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2020
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/10f29c0b839447ca9274efd0052024a5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Statins and Insulin Resistance
por: GM Sanvee, et al.
Publicado: (2020)

Role of PGC-1-alpha-associated Mitochondrial Biogenesis in Statin-induced Myotoxicity
por: M Panajatovic, et al.
Publicado: (2020)

Heart Failure and Cancer: Mechanisms of Old and New Cardiotoxic Drugs in Cancer Patients
por: Alessandra Cuomo, et al.
Publicado: (2019)

Angiotensin receptor-neprilysin inhibition by sacubitril/valsartan attenuates doxorubicin-induced cardiotoxicity in a pretreatment mice model by interfering with oxidative stress, inflammation, and Caspase 3 apoptotic pathway
por: Ferhat Dindaş, et al.
Publicado: (2021)

Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysis
por: Muhammad Mustafa Alhussein, MD, et al.
Publicado: (2021)

Tyrosine Kinase Inhibitors-Induced Arrhythmias: From Molecular Mechanisms, Pharmacokinetics to Therapeutic Strategies
por: Mengfei Cheng, et al.
Publicado: (2021)

Prognostic value of GLS for early prediction of chemotherapy induced cardiotoxicity
por: Sumit Vipin Kumar, et al.
Publicado: (2021)

Evaluation of the efficacy of global longitudinal strain in detection of anthracycline chemotherapy related cardiotoxicity
por: Rajesh Natuva, et al.
Publicado: (2021)

Current Evidence and Future Directions of PCSK9 Inhibition
por: Jiaqian Xu, et al.
Publicado: (2021)

Sodium–Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes
por: Muhammad Shahzeb Khan, et al.
Publicado: (2019)

Sodium–Glucose Co-transporter 2 Inhibitors in Heart Failure: Recent Data and Implications for Practice
por: Giuseppe Rosano, et al.
Publicado: (2020)

Treatment of Heart Failure with Sodium-Glucose Cotransporter 2 Inhibitors and Other Anti-diabetic Drugs
por: Thomas A Zelniker, et al.
Publicado: (2019)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Marco Rossato, et al.
Publicado: (2020)

Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction
por: Giuseppe MC Rosano, et al.
Publicado: (2019)

Use of Renin–Angiotensin–Aldosterone System Inhibitors in Older Patients with Heart Failure and Reduced Ejection Fraction
por: Davide Stolfo, et al.
Publicado: (2019)

A young patient with acute myocardial infarction due to bonsai treated with glycoprotein IIbIIIa inhibitor
por: Ömer Doğan, et al.
Publicado: (2021)

Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments
por: Juan Tamargo
Publicado: (2019)

An updated perspective and pooled analysis of cardiovascular outcome trials of GLP-1 receptor agonists and SGLT-2 inhibitors
por: Mustafa Kılıçkap, et al.
Publicado: (2021)

Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments
por: Juan Tamargo
Publicado: (2019)

Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Maki Komiyama, et al.
Publicado: (2020)

Practicability of Bivalirudin plus Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis
por: Senjie Li, et al.
Publicado: (2021)

Non-invasive cardiac imaging for evaluation of cardiotoxicity in cancer patients - early detection and follow-up
por: Gabriel Vorobiof, et al.
Publicado: (2017)

Takotsubo syndrome early after treatment due to non cardiotoxic chemotherapy agents
por: Benay Özbay, et al.
Publicado: (2021)

The impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction
por: Osama A. Amin, et al.
Publicado: (2021)

Using biomarkers and early prophylactic treatment to prevent cardiotoxicity in cancer patients on chemotherapy
por: Giulia Bacchiani, et al.
Publicado: (2017)

The Role of C-reactive Protein in Patient Risk Stratification and Treatment
por: Ramón Arroyo-Espliguero, et al.
Publicado: (2021)

Founder mutation in myosin-binding protein C with an early onset and a high penetrance in males
por: Raquel Yotti, et al.
Publicado: (2021)

Effects of SGLT-2 inhibitor on myocardial fibrosis and left ventricular reverse remodeling
por: Dipak Katare, et al.
Publicado: (2021)

The Fate of the Superior Mesenteric Artery in Fenestrated Endovascular Repair of Complex Abdominal Aortic Aneurysms
por: Yongcheng Xu, et al.
Publicado: (2019)

Everything in Moderation: Investigating the U-Shaped Link Between HDL Cholesterol and Adverse Outcomes
por: Marc P Allard-Ratick, et al.
Publicado: (2019)

Ultrafiltration in Acute Heart Failure
por: Maria Rosa Costanzo
Publicado: (2019)

Insights and Clinical Implications from the pELVIS Registry for the Treatment of Aneurysms Involving the Iliac Bifurcation
por: Gergana T Taneva, et al.
Publicado: (2019)

Biomarkers in Routine Heart Failure Clinical Care
por: Sunil K Nadar, et al.
Publicado: (2019)

Coronary Artery Spasm and Perivascular Adipose Tissue Inflammation: Insights From Translational Imaging Research
por: Kazuma Ohyama, et al.
Publicado: (2019)

Focusing on Referral Rather than Selection for Advanced Heart Failure Therapies
por: Tonje Thorvaldsen, et al.
Publicado: (2019)

Insights for Stratification of Risk in Brugada Syndrome
por: Daniel García Iglesias, et al.
Publicado: (2019)

The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
por: Sotirios Tsalamandris, et al.
Publicado: (2019)

Role of High-sensitivity Cardiac Troponin in Acute Coronary Syndrome
por: Mahesh Anantha Narayanan, et al.
Publicado: (2019)

Below-the-ankle Angioplasty: Current Evidence and Future Perspectives
por: Stavros Spiliopoulos, et al.
Publicado: (2019)

Introducing Vernakalant into Clinical Practice
por: Angela JM Hall, et al.
Publicado: (2019)